As ordered reported by the Senate Committee on Commerce, Science, and Transportation on September 17, 2014
S. 2338 would authorize appropriations of $91 million over the 2014-2020 period for the United States Anti-Doping Agency (USADA) to prevent the use of performance-enhancing drugs in Olympic sports. Assuming appropriation of the authorized amounts, CBO estimates that implementing S. 2338 would cost $65 million over the 2015-2019 period and $14 million in 2020. (There would be no effect in 2014 since the fiscal year is over.) Enacting the bill would not affect direct spending or revenues.
S. 2338 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would not affect the budgets of state, local, or tribal governments.